![](https://6c47780c70.clvaw-cdnwnd.com/5bc4725fe4d940fd0ea9134fd65234bf/200000044-a58e7a58e9/Slide2-5.jpeg?ph=6c47780c70)
Patient preferences for care for metabolic dysfunction associated steatotic liver disease (MASLD):
Let's move towards patient-centred care
![](https://6c47780c70.clvaw-cdnwnd.com/5bc4725fe4d940fd0ea9134fd65234bf/200000006-d5037d503a/liver%20image-9.jpeg?ph=6c47780c70)
Metabolic dysfunction associated steatotic liver disease (MASLD)
• MASLD (fatty liver disease) occurs when there is excess fat in the liver
• MASLD affects 1 in 3 men & 1 in 4 women in UK
• The main causes of MASLD are obesity & type 2 diabetes
• While there is no drug treatment for MASLD, weight loss can reverse disease progression
Research participants - we want to hear from you
• We are looking for people to attend an interview, or small discussion group to ask people about their preferences regarding care for fatty liver disease
• The discussion can take place online / in person / telephone depending on your preference
• The discussion will take between 30 mins to 2 hours
• All participants enrolled will be paid £25/hr for their time via a amazon voucher
• Findings will be used to design a patient-centred' model of care for people with fatty liver disease
• Please do not worry if you do not know anything about fatty liver disease, no prior knowledge is required!
Am I eligible to take part?
We would like to speak to anyone who is over 18 years old and either:
1. Is living with being overweight or type 2 diabetes
OR
2. Has a diagnosis of fatty liver disese (MASLD) from your GP or the hospital
* Excluding people who drink high levels of alcohol
![](https://6c47780c70.clvaw-cdnwnd.com/5bc4725fe4d940fd0ea9134fd65234bf/200000008-ed5afed5b4/discussion%20group%20image.png?ph=6c47780c70)
Research Team
Dr Theresa Hydes, NIHR Clinical Lecturer in Hepatology (Study lead)
Katie Williams, PhD student (Research Assistant)
Get in touch
If you are interested in taking part please email us with your name and we will contact you back. Thank you!
Participating sites: Primary care
Millbrook Medical Centre (Liverpool),
Mike Merriman
Solent Health (Southampton), Tina Reinson
Bellingham Practice (Northumberland),
Helen Jarvis
Llandaff and Pentyrch
surgery (Wales), Sophie Davies
Ashgrove Surgery (Wales), Tom Hodges-Hoyland
Marine Lake Medical Practice (Wirral), James Perry
Ashfields
Primary Care Centre (Cheshire), Neil Paul
Fernhead
Cross Medical Centre (Warrington), Dawn Tragen
The
Eric Moore Partnership (Warrington), Dr Mariscal
Carn to
Coast Health Centres
(Cornwall), John Madine
The
Atlantic Medical Group (Cornwall), John Ryan
Pathfields Medical Group (Plymouth), James Boorer
Little Harwood Health Centre (Blackburn), Javed Shaikh
Garswood
Surgery (Wigan), Nicola Horrigan
Station
House Surgery (Cumbria), David Cowling
Fulwood Green Medical Centre (Liverpool), Jamie Hampson
Princess Street Practice (London), Dr Osonuga
Decima Street Surgery (London), Dr Osonuga
East of England Priamry Care Practices are also promoting this study
Participating sites: Secondary care
Aintree University Hospital, Theresa Hydes/Cyril Sieberhagen
Royal Liverpool University Hospital, Omar Elshaarawy
Barts NHS Foundation Trust, Will Alazawi
Imperial NHS Foundation Trust, Pinelopi Manasou
Southampton NHS Foundation Trust, Ryan Buchanan
Swansea NHS Foundation Trust, Jag Nagaraj
University Hospitals Plymouth NHS Foundation Trust, Charlotte Williams
Find out more about fatty liver disease
![](https://duyn491kcolsw.cloudfront.net/files/1a/1ai/1ai4k6.jpg?ph=6c47780c70)